Literature DB >> 5420103

Drug-induced inhibition of tumour cell dissemination.

K Burrage, K Hellmann, A J Salsbury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5420103      PMCID： PMC1703018     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Control of malignant metastases by ICRF l59.

Authors:  K Hellmann; K Burrage
Journal:  Nature       Date:  1969-10-18       Impact factor: 49.962

2.  Antitumour activity in a series of bisdiketopiperazines.

Authors:  A M Creighton; K Hellmann; S Whitecross
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

3.  Preliminary clinical assessment of I.C.R.F. 159 in acute leukaemia and lymphosarcoma.

Authors:  K Hellmann; K A Newton; D N Whitmore; I W Hanham; J V Bond
Journal:  Br Med J       Date:  1969-03-29
  3 in total
  3 in total

1.  Vascular changes in tumours after treatment with ICRF 159.

Authors:  A W Le Serve; K Hellmann
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

2.  Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristic.

Authors:  A J Salsbury; K Burrage; K Hellmann
Journal:  Br Med J       Date:  1970-11-07

3.  Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action.

Authors:  A W Le Serve; K Hellmann
Journal:  Br Med J       Date:  1972-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.